US5019513AExpiredUtility

Anti-bacterial T-cell factor

44
Assignee: BRIGHAM & WOMENS HOSPITALPriority: Jun 4, 1985Filed: Jan 12, 1989Granted: May 28, 1991
Est. expiryJun 4, 2005(expired)· nominal 20-yr term from priority
C12N 5/163A61K 38/00C07K 14/4703C12N 2510/02
44
PatentIndex Score
8
Cited by
25
References
5
Claims

Abstract

A method of protecting a mammal against a pathogenic bacterium by administering a soluble suppressor T-cell factor derived from a mammal that has been immunized with the bacterium or an antigenic surface fragment of the bacterium. Also disclosed are a hybrid cell fusion of an immunized suppressor T cell, methods of making such cells, and method of producing soluble suppressor T-cell factors.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A hybrid cell producing a water-soluble factor, wherein said factor protects against formation of abscesses caused by Bacteroides fragilis bacterium, said cell comprising a fusion product of: (1) a suppressor T cell from a mammal immunized with said bacterium or a capsular polysaccharide thereof; and   (2) a thymoma cell.   
     
     
       2. The hybrid cell of claim 1 wherein said mammalian suppressor T cell is a rat or mouse cell. 
     
     
       3. The hybrid cell of claim 1 wherein said bacterium is from the species B. fragilis. 
     
     
       4. The hybrid cell of claim 1 wherein said thymoma cell is derived from cell line BW ATCC 5147. 
     
     
       5. The hybrid cell of claim 1 wherein said hybrid cell is identical to or subcloned from the deposit designated ATCC HB 8004.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.